Inicio>>Signaling Pathways>> Microbiology & Virology>> Bacterial>>Davercin

Davercin (Synonyms: Erythromycin cyclocarbonate)

Catalog No.GC43381

Davercin (Ciclocarbonato de Eritromicina), derivado de la Eritromicina, que es activo frente a microorganismos Gram-positivos y algunos Gram-negativos.

Products are for research use only. Not for human use. We do not sell to patients.

Davercin Chemical Structure

Cas No.: 55224-05-0

Tamaño Precio Disponibilidad Cantidad
1mg
67,00 $
Disponible
5mg
138,00 $
Disponible
10mg
225,00 $
Disponible
25mg
357,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Davercin (Erythromycin Cyclocarbonate), derivative of Erythromycin, which is active against Gram-positive and some Gram-negative microorganisms.

Erythromycin is used in treatment of respiratory, gastrointestinal, and genital tract infections, as well as skin and soft tissue infections. Erythromycin, with its ten chiral centers and two sugar substituents (L-cladinose and D-desosamine), is a good starting point for numerous medicinal chemistry efforts for improvement of its biological profile (better activity, higher stability, and improved bioavailability) since the first generation of macrolides, which had low toxicity and good tolerability, are unstable in acidic media, had low toxicity and good tolerability[1].

References:
[1]. Jelic D, et al. From Erythromycin to Azithromycin and New Potential Ribosome-Binding Antimicrobials. Antibiotics (Basel). 2016 Sep 1;5(3). pii: E29.

Reseñas

Review for Davercin

Average Rating: 5 ★★★★★ (Based on Reviews and 28 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Davercin

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.